ArticleJournal of family & community medicine2013
The prevalence of pterygium in Alkhobar: A hospital-based study.
Article in Journal of family & community medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Network toxicology, transcriptomics, and cytotoxic validation reveal TDCPP-induced pterygium mechanisms.Scientific reports · 2025Article
- Identification of biomarkers and immune microenvironment associated with pterygium through bioinformatics and machine learning.Frontiers in molecular biosciences · 2024Article
- Regenerated Corneal Epithelium Expresses More βIII-Tubulin After Chemical Injuries Compared to Mechanical Injuries.Translational vision science & technology · 2023Article
- Evaluation of the Algerbrush II rotating burr as a tool for inducing ocular surface failure in a mouse model.Molecular vision · 2023Article
- Artificial intelligence assisted pterygium diagnosis: current status and perspectives.International journal of ophthalmology · 2023Article
- Characteristics and recurrence of pterygium in Saudi Arabia: a single center study with a long follow-up.BMC ophthalmology · 2021Article
- Prevalence of Pterygium and Associated Risk Factors in the High-Altitude Area of Ta'if City, Saudi Arabia.Cureus · 2021Article
- Evaluation of Cyclooxygenase-2 and p53 Expression in Pterygium Tissue Following Preoperative Intralesional Ranibizumab Injection.Frontiers in medicine · 2021Article
- Prevalence and Associated Factors of Pterygium Among Adults Living in Kolla Diba Town, Northwest Ethiopia.Clinical ophthalmology (Auckland, N.Z.) · 2020Article
- The prevalence and determinants of pterygium in rural areas.Journal of current ophthalmology · 2017Article
- The use of dry amniotic membrane in pterygium surgery.Clinical ophthalmology (Auckland, N.Z.) · 2016Review
- The astigmatic effect of pterygium in a Tertiary Hospital in Kano, Nigeria.Annals of African medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the epidemiology of pterygium in a hospital-based population in Alkhobar, which is located in the eastern province of Saudi Arabia. MATERIALS AND
methodsThis was a retrospective, non-randomized, and consecutive case study. Out of 88,666 patients who were seen in the ophthalmology clinic between January 1995 through the end of December 2010, 116 patients were diagnosed with advanced pterygium. The medical records of these patients were evaluated.
resultsThe overall prevalence of pterygium was found to be 0.074%. There was no significant difference by either gender, side, or by laterality (P > 0.05). A significant increase was noticed in the prevalence of pterygium with increasing age and nasal location (P < 0.05).
conclusionThe overall prevalence rate of pterygium in Alkhobar is low when compared with results reported from other areas of the world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.